11/20
10:24 am
vir
Vir Biotechnology, Inc. (NASDAQ: VIR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $110.00 price target on the stock.
Low
Report
Vir Biotechnology, Inc. (NASDAQ: VIR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $110.00 price target on the stock.
11/20
08:07 am
vir
Vir Biotechnology, Inc. (NASDAQ: VIR) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $19.00 price target on the stock.
Medium
Report
Vir Biotechnology, Inc. (NASDAQ: VIR) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $19.00 price target on the stock.
11/20
04:29 am
vir
Rating for VIR
Medium
Report
Rating for VIR
11/20
04:29 am
vir
Rating for VIR
Medium
Report
Rating for VIR
11/4
08:19 am
vir
Vir Biotechnology, Inc. (NASDAQ: VIR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $110.00 price target on the stock.
Low
Report
Vir Biotechnology, Inc. (NASDAQ: VIR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $110.00 price target on the stock.
11/4
07:17 am
vir
Rating for VIR
Low
Report
Rating for VIR
11/4
07:17 am
vir
Rating for VIR
Low
Report
Rating for VIR
11/1
08:15 am
vir
Vir Biotechnology, Inc. (NASDAQ: VIR) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $19.00 price target on the stock.
High
Report
Vir Biotechnology, Inc. (NASDAQ: VIR) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $19.00 price target on the stock.
11/1
06:08 am
vir
Rating for VIR
High
Report
Rating for VIR
11/1
06:08 am
vir
Rating for VIR
High
Report
Rating for VIR